025: Genetic and epigenetic drivers of high risk blastemal Wilms tumors

HIPO Investigator:

Prof. Gessler

Prof. Pfister

Supported by: HIPO/NCT-POP

Entity: Wilms tumors


Wegert J, et al.; TP53 alterations in Wilms tumor represent progression events with strong intratumor heterogeneity that are closely linked, but not limited to anaplasia. The Journal of Pathology: Clinical Research 2017

Wegert J et al.; Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors, Cancer Cell 2015

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline